Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorJakub Antczak

About this trial

Intermittent and continuous theta-burst stimulation (iTBS and cTBS respectively) are the newer modalities of transcranial magnetic stimulation with documented efficacy in treatment of depressed mood but with conflicting results regarding their efficacy in treatment of other symptoms of depression such as insomnia, daytime sleepiness and fatigue. This study will investigate the efficacy of iTBS over the left dorsolateral prefrontal cortex (DLPFC) and cTBS over the right DLPFC, compared to sham stimulation, in treatment of insomnia, daytime sleepiness and fatigue in depression.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

severe or moderate depressive episode (according to international classification of diseases (ICD)-10) without psychotic symptoms at the time of inclusion

Diagnosis of major depression (F33.1 or F33.2) or bipolar disorder (F31.3 or F31.4).

The score of the Athens Insomnia Scale five or more

Unchanged antidepressive pharmacotherapy at least one month prior to inclusion

Disqualifiers

Contraindications to transcranial magnetic stimulation, including ferromagnetic elements in head, pregnancy and epilepsy

Psychotic symptoms at the time of inclusion

Suicidal ideations and/or attempts within three months prior to inclusion

Trial design

Design model

Parallel

Treatments tested in this trial

  • iTBS

    Device

    Active iTBS over the left DLPFC to induce the long term potentiation of stimulated area.

  • cTBS

    Device

    Active cTBS over the right DLPFC to induce the long term potentiation of stimulated area.

  • Sham

    Device

    Sham iTBS or cTBS over the left or right DLPFC respectively for placebo.

Treatment groups

90 Participants
are divided into 3 treatment groups
Group A: iTBS over the left DLPFCActive comparator 1 intervention
Group B: cTBS over the right DLPFCExperimental treatment 1 intervention
Group C: Sham stimulationSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Beck Depression Inventory 2

Inventory consisting of 21 items measuring cognitive, affective, somatic, and vegetative symptoms of depression. Each item is scored from 0 to 3, with a higher score denoting more severe depression. Items are related to the criteria from the Diagnostic and Statistical Manual of Mental Disorders-IV. The minimum value of the total score is 0 and the maximum is 63 with higher scores meaning worse outcome. Change from the baseline to the measurement done after finishing intervention, to the measurement done two weeks after finishing intervention to the measurement done four weeks after finishing intervention.

Time frame
Before intervention - four weeks after finishing intervention.
2

Pittsburgh Sleep Quality Index

Pittsburgh Sleep Quality Index is a questionnaire to identify sleep disturbances. It consists of a combination of Likert-type and open-ended questions, which are later converted to scaled scores. Scores for each question range from 0 to 3, with higher scores indicating greater sleep disturbances. The minimum value of the total score is 0 and the maximum is 21 with higher scores meaning worse outcome. Change from the baseline to the measurement done after finishing intervention, to the measurement done two weeks after finishing intervention to the measurement done four weeks after finishing intervention.

Time frame
Before intervention - four weeks after finishing intervention.

Secondary outcomes

1

Brief Psychiatric Rating Scale

An 18-item scale assessing negative symptoms, such as emotional withdrawal (e.g. withdrawal from relations), motor slowness and blunted affect. Each item is rated from 1 to 7 with 7-point Likert scaling, where 7 means the most severe disturbance. The minimum value of the total score is 18 and the maximum is 126 with higher scores meaning worse outcome. Change from the baseline to the measurement done after finishing intervention, to the measurement done two weeks after finishing intervention to the measurement done four weeks after finishing intervention.

Time frame
Before intervention - four weeks after finishing intervention.
2

Epworth Sleepiness Scale

An eight-item scale. Each item refers to a situation such as driving a car or sitting quietly. The subject is asked to assess the chance of dosing in each situation, ranging from 0 (no chance) to 3 (dosing very likely). The minimum value of the total score is 0 and the maximum is 24 with higher scores meaning worse outcome. Change from the baseline to the measurement done after finishing intervention, to the measurement done two weeks after finishing intervention to the measurement done four weeks after finishing intervention.

Time frame
Before intervention - four weeks after finishing intervention.
3

Fatigue Assessment Scale

A 10-item scale to assess the severity of fatigue. Each item is an expression describing the fatigue, such as: "I am bored by fatigue" or "Mentally I feel exhausted". Each item is answered using a Likert-type scale ranging from 1 (never) to 5 (always). The minimum value of the total score is 10 and the maximum is 50 with higher scores meaning worse outcome. Change from the baseline to the measurement done after finishing intervention, to the measurement done two weeks after finishing intervention to the measurement done four weeks after finishing intervention.

Time frame
Before intervention - four weeks after finishing intervention.
4

Quality of Life in Depression Scale

A 34-item, self-reported scale to assess the impact of depression on the quality of life. The scale is scored binomially with higher scores indicating a lower quality of life. The minimum value of the total score is 0 and the maximum is 34 with higher scores meaning worse outcome. Change from the baseline to the measurement done after finishing intervention, to the measurement done two weeks after finishing intervention to the measurement done four weeks after finishing intervention.

Time frame
Before intervention - four weeks after finishing intervention.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jakub Antczak

Lead sponsor

Jagiellonian University

Sponsor institution

Institute of Psychiatry and Neurology, Warsaw

Collaborator